Skip to main content
Premium Trial:

Request an Annual Quote

Bioké Inks Distribution Deal for Syntec Sample Prep Products

NEW YORK (GenomeWeb) — Dutch laboratory equipment supplier Bioké announced today that it has signed an agreement to exclusively distribute Ireland-based Syntec's Medimachine line of semi-automated homogenizer products in the Netherlands, Belgium, and Luxembourg.

Financial terms of the deal were not disclosed.

Syntec's Medimachine product line includes the Medimachine II instrument for gentle tissue dissociation and fine homogenization. "The improved Medimachine II and corresponding consumables can be used for both dissociation of tissues into single-cell suspensions and for mechanical disaggregation of solid animal or plant tissues for flow cytometric analysis, cell culture, or DNA amplification techniques," Syntec Managing Director Ray Sinnott said in a statement. "This makes the Medimachine II the most versatile semi-automated homogenizer on the market."

Earlier this year, Bioké acquired the rights to distribute Namocell's Namo Single Cell Dispenser tool in the Netherlands, Belgium, and Luxembourg. It has also recently signed similar deals for Bethyl Laboratories' catalogue of products and Acea Biosciences' xCelligence cell analyzer.

The Scan

Cancer Survival Linked to Mutational Burden in Pan-Cancer Analysis

A pan-cancer paper appearing in JCO Precision Oncology suggests tumor mutation patterns provide clues for predicting cancer survival that are independent of other prognostic factors.

Australian Survey Points to Public Support for Genetic Risk Disclosure in Relatives of At-Risk Individuals

A survey in the European Journal of Human Genetics suggests most adult Australians are in favor of finding out if a relative tests positive for a medically actionable genetic variant.

Study Links Evolution of Stony Coral Skeleton to Bicarbonate Transporter Gene

A PNAS paper focuses on a skeleton-related bicarbonate transporter gene introduced to stony coral ancestors by tandem duplication.

Hormone-Based Gene Therapy to Sterilize Domestic Cat

A new paper in Nature Communication suggests that gene therapy could be a safer alternative to spaying domestic cats.